Published

Psychedelics not linked to mental health problems or suicidal behavior: a population study.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2015-03-01
Source: PubMed
DOI: 10.1177/0269881114568039
PubMed: 25744618

Authors

Johansen PØ Krebs TS

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction Safety Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Prevalence and Correlates of Past-Year Psilocybin Use in the United States2026-04-22 Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms2025-07-22 Psychedelics not linked to mental health problems or suicidal behavior: a population study.2015-03-01

Related papers

Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-04 Beyond prohibition: A public health analysis of naturalistic psychedelic useJournal of Psychedelic Studies · 2025-07-03 Low-income group psilocybin assisted therapy for depression: An Oregon feasibility studyJournal of Psychedelic Studies · 2026-02-12 Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-20 Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.Addiction (Abingdon, England) · 2025-09-20 Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disordersPsychedelics. · 2025-06-10 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)ClinicalTrials.gov · 2026-07-09